Stephen Mandel’s Lone Pine Capital disclosed in an SEC filing its holdings as of December 31, 2024. Lone Pine’s four new buys during the fourth ...
From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback